Case report: Agranulocytosis attributed to levamisole-tainted cocaine

American Family Physician

Volumn 84, Issue 4, 2011, Pages 355-

  Chapman, Duncan ^a   Khodaee, Morteza ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CANNABINOID; COCAINE; LEVAMISOLE; OPIATE DERIVATIVE;

ABSCESS DRAINAGE; ADULT; AGRANULOCYTOSIS; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; DRUG CONTAMINATION; DYSPNEA; FEVER; HUMAN; HUMAN CELL; LETTER; MALE; MYALGIA; NEUTROPENIA; NEUTROPHIL COUNT; PERITONSILLAR ABSCESS; SORE THROAT;

EID: 80051760722     PISSN: 0002838X     EISSN: 15320650     Source Type: Journal    
DOI: None     Document Type: Letter

References (6)

1. Buchanan JA, et al. A confirmed case of agranulocytosis after use of cocaine contaminated with levamisole. J Med Toxicol. 2010;6(2):160-164.
2. Knowles L, et al. Levamisole tainted cocaine causing severe neutropenia in Alberta and British Columbia. Harm Reduct J. 2009;6:30.
3. Centers for Disease Control and Prevention. Agranulocytosis associated with cocaine use-four States, March 2008-November 2009. MMWR Morb Mortal Wkly Rep. 2009;58(49):1381-1385.
4. Czuchlewski DR, et al. Clinicopathologic features of agranulocytosis in the setting of levamisole-tainted cocaine. Am J Clin Pathol. 2010;133(3):466-472.
5. Zhu NY, et al. Agranulocytosis after consumption of cocaine adulterated with levamisole. Ann Intern Med. 2009;150(4):287-289.
6. Chang A, et al. Levamisole: a dangerous new cocaine adulterant. Clin Pharmacol Ther. 2010;88(3):408-411.